APGE (NASDAQ: APGE) holder plans sale of 1.75M common shares
Rhea-AI Filing Summary
A holder of Apogee Therapeutics (symbol APGE) common stock filed a Form 144 notice to potentially sell 1,750,000 shares through broker Jefferies LLC on or about 01/22/2026 on the NASDAQ. The filing lists an aggregate market value for the planned sale of $133,525,000.00, based on current market prices, compared with 54,833,587 shares of the class outstanding. The shares were originally purchased in the initial public offering on 07/13/2023 from the issuer for cash, with payment dated 07/18/2023.
By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations, and acknowledges that intentional misstatements or omissions would be a federal criminal violation.
Positive
- None.
Negative
- None.
Insights
Large Form 144 sale notice, but informational rather than thesis-changing.
The Form 144 indicates an intent to sell 1,750,000 common shares, with an aggregate market value of
The filing names Jefferies LLC as broker and the NASDAQ as the exchange, suggesting ordinary market transactions rather than a special structured deal. The signer represents they do not know of undisclosed material adverse information about the issuer’s operations. Actual market impact, if any, would depend on execution of the sales and prevailing trading liquidity.
FAQ
What does APGE's Form 144 filing disclose?
It discloses that a holder of APGE common stock has filed a notice of intent to sell 1,750,000 shares on the NASDAQ through Jefferies LLC, with an indicated aggregate market value of
How large is the planned APGE share sale compared to shares outstanding?
The Form 144 lists 1,750,000 common shares to be sold and shows 54,833,587 shares of that class outstanding at the time, providing context for the size of the potential sale.
When were the APGE shares in this Form 144 originally acquired?
The filing states the common shares were purchased in the initial public offering on
What is the approximate date of sale in APGE's Form 144 notice?
The notice specifies an approximate sale date of 01/22/2026 for the 1,750,000 common shares to be sold on the NASDAQ.
Which broker is handling the potential APGE Form 144 sale?
The Form 144 identifies Jefferies LLC, located at 520 Madison Ave, New York, NY 10022, as the broker for the planned sale of APGE common shares.
What representation does the seller make in the APGE Form 144?
By signing, the seller represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and acknowledges that intentional misstatements or omissions are federal criminal violations.